Close Menu

Pacific Biosciences' sequencer has made it from idea to tangible product, with its recent shipments of its PacBio RS instrument — though this BusinessWeek article points out that sequencing has been, and will continue to be, a challenging field for a company to make its mark on. However, PacBio is hopeful about its sequencing technology. "The ability to observe these things in real time has been the goal of modern biology for the last 50 years," says CSO Eric Schadt.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.